NCT04705935View on ClinicalTrials.gov

Amniochorionic Membrane Cells in the Maternal Blood as a Biomarker for Preterm Birth

CompletedOBSERVATIONAL
Enrollment

83

Participants

Timeline

Start Date

August 15, 2022

Primary Completion Date

June 28, 2024

Study Completion Date

June 28, 2024

Conditions
Preterm BirthPreterm Premature Rupture of MembranePreterm Labor
Trial Locations (1)

8200

Aarhus University Hospital, Aarhus

Sponsors

Collaborators (1)

Arcedi Biotech
All Listed Sponsors
collaborator

Arcedi Biotech

INDUSTRY

collaborator

Aarhus University Hospital

OTHER

collaborator

The University of Texas Medical Branch, Galveston

OTHER

collaborator

Medical University of Graz

OTHER

lead

University of Aarhus

OTHER

NCT04705935 - Amniochorionic Membrane Cells in the Maternal Blood as a Biomarker for Preterm Birth | Biotech Hunter | Biotech Hunter